Diseases/Conditions News Headlines - Yahoo! News

http://news.yahoo.com/diseases/ Get the latest Diseases/Conditions news headlines from Yahoo! News. Find breaking Diseases/Conditions news, including analysis and opinion on top Diseases/Conditions stories, photos and more.en-USCopyright (c) 2013 Yahoo! Inc. All rights reservedFri, 12 Jul 2013 17:34:15 -04005http://news.yahoo.com/diseases/ http://l.yimg.com/a/i/us/nws/th/main_142c.gifWASHINGTON (Reuters) - A Montana man charged with selling unapproved cancer drugs was sentenced to five years probation and six months of home confinement, U.S. law enforcement authorities said on Friday. He was also forced to forfeit some $6 million in assets. The case is the latest in roughly a dozen brought by the U.S. Department of Justice and Food and Drug Administration against distributors of unapproved pharmaceuticals. Under the latest sentencing, in U.S. District Court in Missoula, Montana, Paul Daniel Bottomley, 48, agreed to forfeit $1. ...http://news.yahoo.com/u-sentences-man-latest-fake-cancer-drug-case-213415099.htmlFri, 12 Jul 2013 17:34:15 -0400Reutersu-sentences-man-latest-fake-cancer-drug-case-213415099By Ransdell Pierson (Reuters) - Despite two failed late-stage trials of its experimental Alzheimer's drug solanezumab, Eli Lilly and Co said on Friday it plans to run yet another study, this time focusing only on mild patients who appeared to respond to the treatment. And the company will take extra steps to ensure it is testing actual Alzheimer's patients by pre-screening them with its imaging agent Amyvid to ensure they have deposits of the protein beta amyloid that is linked with the disease. ...http://news.yahoo.com/lilly-plans-big-alzheimers-disease-study-prior-failures-130413774.htmlFri, 12 Jul 2013 14:56:39 -0400Reuterslilly-plans-big-alzheimers-disease-study-prior-failures-130413774Kathryn Doyle NEW YORK (Reuters Health) - When babies already at increased risk for type 1 diabetes had their first solid foods before four months of age or after six months, their chances of developing the disorder at least doubled, according to a new study. Four to six months is the recommended age window for all kids to start on solid foods, but the new results suggest timing could be even more important for babies at high risk for type 1 diabetes (T1D) because of genetic susceptibility. ...http://news.yahoo.com/timing-first-solid-food-tied-child-diabetes-risk-183615783.htmlFri, 12 Jul 2013 14:36:15 -0400Reuterstiming-first-solid-food-tied-child-diabetes-risk-183615783By Genevra Pittman NEW YORK (Reuters Health) - Research has long shown slight health differences among babies born at different times during the year, and a new study suggests seasonal flu may be a contributing factor. In the study of over 600,000 women who each had more than one child, researchers found a dip in average pregnancy length - and thus an increase in premature births - for infants conceived in May. Most of those babies were born at the height of flu season, in early- to mid-winter. ...http://news.yahoo.com/flu-may-explain-seasonal-birth-differences-study-163327203.htmlFri, 12 Jul 2013 12:33:27 -0400Reutersflu-may-explain-seasonal-birth-differences-study-163327203Retired Philadelphia Phillies catcher?Darren Daulton revealed he was diagnosed with glioblastoma. That makes seven Major League Baseball (MLB) players or managers to succumb to the disease in recent years. Is there a cancer cluster in baseball?http://news.yahoo.com/another-case-brain-cancer-baseball-going-160001552.htmlFri, 12 Jul 2013 12:00:01 -0400Time.comanother-case-brain-cancer-baseball-going-160001552<p><a href="http://news.yahoo.com/fda-approves-boehringer-drug-treat-advanced-lung-cancer-142657263.html"><img src="http://l.yimg.com/bt/api/res/1.2/AzCalg1.1Li4slhAoYjT7A--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2013-07-12T142657Z_1_CBRE96B145300_RTROPTP_2_CHINA-PHARMACEUTICALS.JPG" width="130" height="86" alt="A view shows the U.S. Food and Drug Administration (FDA) headquarters in Silver Spring" align="left" title="A view shows the U.S. Food and Drug Administration (FDA) headquarters in Silver Spring" border="0" /></a>(Reuters) - The U.S. Food and Drug Administration approved a lung cancer drug made by Boehringer Ingelheim to treat patients who are suffering from late stage non-small cell lung cancer and whose tumors express a specific type of gene mutation. The drug, Gilotrif, was approved along with a companion diagnostic kit that can help determine if a patient&#039;s lung cancer cells express the epidermal growth factor receptor (EGFR) gene mutation. Non-small cell lung cancer (NSCLC) is the most common type of lung cancer and represents about 85 percent of all lung cancers. ...</p><br clear="all"/>http://news.yahoo.com/fda-approves-boehringer-drug-treat-advanced-lung-cancer-142657263.htmlFri, 12 Jul 2013 10:26:57 -0400Reutersfda-approves-boehringer-drug-treat-advanced-lung-cancer-142657263<p><a href="http://news.yahoo.com/fda-approves-boehringer-drug-treat-advanced-lung-cancer-142657263.html"><img src="http://l.yimg.com/bt/api/res/1.2/AzCalg1.1Li4slhAoYjT7A--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2013-07-12T142657Z_1_CBRE96B145300_RTROPTP_2_CHINA-PHARMACEUTICALS.JPG" width="130" height="86" alt="A view shows the U.S. Food and Drug Administration (FDA) headquarters in Silver Spring" align="left" title="A view shows the U.S. Food and Drug Administration (FDA) headquarters in Silver Spring" border="0" /></a>(Reuters) - The U.S. Food and Drug Administration approved a lung cancer drug made by Boehringer Ingelheim to treat patients who are suffering from late stage non-small cell lung cancer and whose tumors express a specific type of gene mutation. The drug, Gilotrif, was approved along with a companion diagnostic kit that can help determine if a patient&#039;s lung cancer cells express the epidermal growth factor receptor (EGFR) gene mutation. Non-small cell lung cancer (NSCLC) is the most common type of lung cancer and represents about 85 percent of all lung cancers. ...</p><br clear="all"/><p><a href="http://news.yahoo.com/disease-killing-off-shrimp-in-east-asia-135629473.html"><img src="http://l3.yimg.com/bt/api/res/1.2/h5Mv11f3Ra.GcJuuuW8NEA--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://l.yimg.com/os/publish-images/news/2013-07-12/a9a8af85-7218-48ef-93cd-088eb0815576_shrimp.jpg" width="130" height="86" alt="Thai shrimp" align="left" title="Thai shrimp" border="0" /></a>A bacterial infection has severely depleted shrimp populations in Thailand and other parts of East Asia, resulting in price rises for restaurants and retailers worldwide.</p><br clear="all"/>http://news.yahoo.com/disease-killing-off-shrimp-in-east-asia-135629473.htmlFri, 12 Jul 2013 09:56:28 -0400disease-killing-off-shrimp-in-east-asia-135629473<p><a href="http://news.yahoo.com/disease-killing-off-shrimp-in-east-asia-135629473.html"><img src="http://l3.yimg.com/bt/api/res/1.2/h5Mv11f3Ra.GcJuuuW8NEA--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://l.yimg.com/os/publish-images/news/2013-07-12/a9a8af85-7218-48ef-93cd-088eb0815576_shrimp.jpg" width="130" height="86" alt="Thai shrimp" align="left" title="Thai shrimp" border="0" /></a>A bacterial infection has severely depleted shrimp populations in Thailand and other parts of East Asia, resulting in price rises for restaurants and retailers worldwide.</p><br clear="all"/>What?s good for the heart may not be so healthy for other organs, says the latest study that links omega-3 fatty acids to an elevated risk of prostate cancer.http://news.yahoo.com/hold-salmon-omega-3-fatty-acids-linked-higher-193019521.htmlThu, 11 Jul 2013 15:30:19 -0400Time.comhold-salmon-omega-3-fatty-acids-linked-higher-193019521(Reuters) - Celgene Corp said a late-stage trial of its cancer drug Revlimid met the main goal of improving survival in newly diagnosed blood cancer patients, potentially opening up the path for a wider use of the drug. The company's shares were up 7 percent at $133.07 in morning trade. Analysts said the data was largely expected and will also pave the way for a European approval application for the drug. Celgene had withdrawn the European marketing application for a wider use of the drug in June 2012, after regulators asked for more data. ...http://news.yahoo.com/celgenes-revlimid-improves-survival-blood-cancer-patients-123449643.htmlThu, 11 Jul 2013 11:53:45 -0400Reuterscelgenes-revlimid-improves-survival-blood-cancer-patients-123449643(Reuters) - Alnylam Pharmaceuticals Inc said an early-stage trial of its gene-based therapy showed the drug was effective in suppressing a protein that causes a rare organ-damaging hereditary disorder. Alnylam shares rose 14 percent to $42.80 in premarket trade. The study was testing a subcutaneously administered version of the drug, ALN-TTR, to treat genetic disorder amyloidosis, which is caused by deposits of protein in tissues and organs. ...http://news.yahoo.com/alnylam-drug-found-effective-treating-rare-genetic-disease-132403151.htmlThu, 11 Jul 2013 09:24:03 -0400Reutersalnylam-drug-found-effective-treating-rare-genetic-disease-132403151By Genevra Pittman NEW YORK (Reuters Health) - People with Alzheimer's disease have a lower risk of cancer than other elderly adults, a new Italian study suggests. Additionally, researchers found that seniors who were diagnosed with cancer were less likely to develop Alzheimer's. Researchers said there are a number of genes that affect both neurology and cancer growth - and pathways by which the two are connected - that could explain the "unexpected" inverse link between the diseases. "Cancer and Alzheimer's have been viewed by researchers as completely separate," said Dr. ...http://news.yahoo.com/alzheimers-tied-less-cancer-vice-versa-210925341.htmlWed, 10 Jul 2013 17:09:25 -0400Reutersalzheimers-tied-less-cancer-vice-versa-210925341<p><a href="http://news.yahoo.com/roche-stops-diabetes-drugs-development-safety-questions-051713237.html"><img src="http://l1.yimg.com/bt/api/res/1.2/6D6GzX92.K3ffymaeAmiqg--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2013-07-10T051713Z_1_CBRE9690EOT00_RTROPTP_2_ROCHE.JPG" width="130" height="86" alt="Logo of Swiss pharmaceutical company Roche is pictured in Rotkreuz" align="left" title="Logo of Swiss pharmaceutical company Roche is pictured in Rotkreuz" border="0" /></a>By Katharina Bart ZURICH (Reuters) - Roche will halt development of a diabetes drug partly because of its undesired side-effects, marking another high-profile setback for the Swiss company as it struggles to diversify outside its core cancer drug portfolio. The news is a fresh blow for Roche&#039;s Basel research operations, known as pRED, which have languished in the shadow of the work done at Genentech, the 2009 acquisition that cooked up Roche&#039;s four top-selling medicines in 2011. ...</p><br clear="all"/>http://news.yahoo.com/roche-stops-diabetes-drugs-development-safety-questions-051713237.htmlWed, 10 Jul 2013 10:24:44 -0400Reutersroche-stops-diabetes-drugs-development-safety-questions-051713237<p><a href="http://news.yahoo.com/roche-stops-diabetes-drugs-development-safety-questions-051713237.html"><img src="http://l1.yimg.com/bt/api/res/1.2/6D6GzX92.K3ffymaeAmiqg--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2013-07-10T051713Z_1_CBRE9690EOT00_RTROPTP_2_ROCHE.JPG" width="130" height="86" alt="Logo of Swiss pharmaceutical company Roche is pictured in Rotkreuz" align="left" title="Logo of Swiss pharmaceutical company Roche is pictured in Rotkreuz" border="0" /></a>By Katharina Bart ZURICH (Reuters) - Roche will halt development of a diabetes drug partly because of its undesired side-effects, marking another high-profile setback for the Swiss company as it struggles to diversify outside its core cancer drug portfolio. The news is a fresh blow for Roche&#039;s Basel research operations, known as pRED, which have languished in the shadow of the work done at Genentech, the 2009 acquisition that cooked up Roche&#039;s four top-selling medicines in 2011. ...</p><br clear="all"/>By Julie Steenhuysen CHICAGO (Reuters) - Alzheimer's experts plan to protest proposed Medicare guidelines that would deny coverage of an Eli Lilly diagnostic test for the disease unless patients are taking part one of several clinical trials in which the $3,000 test is being used. Eli Lilly and Co and the Alzheimer's Association have objected to the draft guidelines, issued last week by the U.S. Centers for Medicare & Medicaid Services, the agency that runs Medicare. Both plan to pressure CMS to change the guidelines, saying they deny some patients the chance to get an accurate diagnosis. ...http://news.yahoo.com/medicare-plan-alzheimers-test-dismays-advocates-233514739.htmlTue, 09 Jul 2013 19:35:14 -0400Reutersmedicare-plan-alzheimers-test-dismays-advocates-233514739By Andrew M. Seaman NEW YORK (Reuters Health) - Men who took soy supplements after having their prostate cancer removed were just as likely to see their cancer return as men who didn't take soy, in a new study. "I think this study clearly demonstrates men in this particular situation? will not benefit," said Maarten Bosland, the study's lead author from the University of Illinois at Chicago. According to the American Cancer Society, prostate cancer is the second most common cancer among men after skin cancer. It's estimated that one in every six men will be diagnosed with it. ...http://news.yahoo.com/soy-doesnt-prevent-prostate-cancer-return-study-205129888.htmlTue, 09 Jul 2013 16:51:29 -0400Reuterssoy-doesnt-prevent-prostate-cancer-return-study-205129888Medicare May Fund Brain Scans for Alzheimer s Researchhttp://news.yahoo.com/medicare-may-fund-brain-scans-alzheimer-research-185200297.htmlTue, 09 Jul 2013 14:52:00 -0400Scientific Americanmedicare-may-fund-brain-scans-alzheimer-research-185200297By Kerry Grens NEW YORK (Reuters Health) - Despite receiving similar cancer treatment as other patients, African Americans with a common form of leukemia didn't live as long in a new study that was aimed at understanding the racial disparity in cancer outcomes. "We don't have an answer" to explain it, said Dr. Alessandra Ferrajoli, the study's senior author and an associate professor of medicine at MD Anderson Cancer Center in Houston. ...http://news.yahoo.com/african-american-blood-cancer-patients-fare-worse-184416134.htmlTue, 09 Jul 2013 14:44:16 -0400Reutersafrican-american-blood-cancer-patients-fare-worse-184416134British researchers have created a new urine tester that can sniff bladder cancer. They expect it will eventually replace the use of repeated scoping to check for new cancer cells and could lower the cost of treating the illness.http://news.yahoo.com/urine-tester-sniff-bladder-cancer-154500013.htmlTue, 09 Jul 2013 11:45:00 -0400Yahoo! Contributor Networkurine-tester-sniff-bladder-cancer-154500013<p><a href="http://news.yahoo.com/tanners-return-booth-skin-cancer-133156624.html"><img src="http://l2.yimg.com/bt/api/res/1.2/GWXDC.aJQnQR_VudFhQF7A--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2013-07-09T133156Z_1_CBRE96811LD00_RTROPTP_2_SOCCER-EURO.JPG" width="130" height="86" alt="A view of a tanning bed at a spa facility at Mistral Hotel in Gniewino" align="left" title="A view of a tanning bed at a spa facility at Mistral Hotel in Gniewino" border="0" /></a>By Kathryn Doyle NEW YORK (Reuters Health) - One in seven people goes back to a tanning bed after being diagnosed with skin cancer, according to a new research letter. Indoor tanning is known to increase a person&#039;s risk for cancer. &quot;The situation may be analogous to that of lung cancer patients who continue to smoke after diagnosis,&quot; said lead author Brenda Cartmel, a cancer prevention researcher at the Yale School of Public Health in New Haven, Connecticut. ...</p><br clear="all"/>http://news.yahoo.com/tanners-return-booth-skin-cancer-133156624.htmlTue, 09 Jul 2013 09:31:56 -0400Reuterstanners-return-booth-skin-cancer-133156624<p><a href="http://news.yahoo.com/tanners-return-booth-skin-cancer-133156624.html"><img src="http://l2.yimg.com/bt/api/res/1.2/GWXDC.aJQnQR_VudFhQF7A--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2013-07-09T133156Z_1_CBRE96811LD00_RTROPTP_2_SOCCER-EURO.JPG" width="130" height="86" alt="A view of a tanning bed at a spa facility at Mistral Hotel in Gniewino" align="left" title="A view of a tanning bed at a spa facility at Mistral Hotel in Gniewino" border="0" /></a>By Kathryn Doyle NEW YORK (Reuters Health) - One in seven people goes back to a tanning bed after being diagnosed with skin cancer, according to a new research letter. Indoor tanning is known to increase a person&#039;s risk for cancer. &quot;The situation may be analogous to that of lung cancer patients who continue to smoke after diagnosis,&quot; said lead author Brenda Cartmel, a cancer prevention researcher at the Yale School of Public Health in New Haven, Connecticut. ...</p><br clear="all"/>LONDON (Reuters) - British pharmaceutical company AstraZeneca has agreed its first research partnerships in Cambridge for cancer treatments ahead of its relocation to the university city by 2016. The firm said it would work on three oncology projects with Cancer Research UK and the University of Cambridge's department of oncology at Addenbrooke's Hospital, located next to the site for its new research center and headquarters. ...http://news.yahoo.com/astrazeneca-signs-first-cambridge-partners-cancer-research-082408940.htmlTue, 09 Jul 2013 04:24:08 -0400Reutersastrazeneca-signs-first-cambridge-partners-cancer-research-082408940By Julie Steenhuysen CHICAGO (Reuters) - Alzheimer's experts are set to protest after Medicare issued draft guidelines last week saying it would only pay for an Eli Lilly and Co diagnostic test for the disease if patients were taking part in clinical trials for it. Both Lilly and the Alzheimer's Association have released statements expressing disappointment with the decision by the U.S. Centers for Medicare & Medicaid Services (CMS), which cited "insufficient" evidence that the tests improve patient care. ...http://news.yahoo.com/groups-dismayed-decision-not-cover-alzheimers-test-041546886.htmlTue, 09 Jul 2013 00:15:46 -0400Reutersgroups-dismayed-decision-not-cover-alzheimers-test-041546886I'm 43, and I've never had allergies before, but I suspect this drippy, headachy feeling I have isn't a cold. Is that possible? - Bill Y.http://onlineathens.com/health/2013-07-08/drs-oz-and-roizen-sudden-onset-allergies-shouldnt-surpriseMon, 08 Jul 2013 19:54:58 -0400health/2013-07-08/drs-oz-and-roizen-sudden-onset-allergies-shouldnt-surprise<p><a href="http://news.yahoo.com/antibody-drug-conjugates-cancer-treatment-making-smart-bombs-105400901.html"><img src="http://l3.yimg.com/bt/api/res/1.2/BispoTizIh5dXkl5UNggtQ--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/ScientificAmerican/sqigg.gif" width="130" height="86" alt="Antibody-Drug Conjugates and Cancer Treatment: Making &quot;Smart Bombs&quot; Smarter" align="left" title="Antibody-Drug Conjugates and Cancer Treatment: Making &quot;Smart Bombs&quot; Smarter" border="0" /></a>Antibody-Drug Conjugates and Cancer Treatment: Making &quot;Smart Bombs&quot; Smarter</p><br clear="all"/>http://news.yahoo.com/antibody-drug-conjugates-cancer-treatment-making-smart-bombs-105400901.htmlThu, 04 Jul 2013 06:54:00 -0400Scientific Americanantibody-drug-conjugates-cancer-treatment-making-smart-bombs-105400901<p><a href="http://news.yahoo.com/antibody-drug-conjugates-cancer-treatment-making-smart-bombs-105400901.html"><img src="http://l3.yimg.com/bt/api/res/1.2/BispoTizIh5dXkl5UNggtQ--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/ScientificAmerican/sqigg.gif" width="130" height="86" alt="Antibody-Drug Conjugates and Cancer Treatment: Making &quot;Smart Bombs&quot; Smarter" align="left" title="Antibody-Drug Conjugates and Cancer Treatment: Making &quot;Smart Bombs&quot; Smarter" border="0" /></a>Antibody-Drug Conjugates and Cancer Treatment: Making &quot;Smart Bombs&quot; Smarter</p><br clear="all"/><p><a href="http://news.yahoo.com/boston-man-quits-job-cure-wifes-rare-cancer-004911331--abc-news-health.html"><img src="http://l1.yimg.com/bt/api/res/1.2/xwMtXtS6MgDDxHTo8y5anw--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://l.yimg.com/os/590/2013/07/04/ht-erica-rick-kaitz-cancer-thg-130703-16x9-992-jpg_110740.jpg" width="130" height="86" alt="Boston Man Quits Job to Find Cure for Wife&#039;s Rare Cancer" align="left" title="Boston Man Quits Job to Find Cure for Wife&#039;s Rare Cancer" border="0" /></a>Orphan Disease Myxoid Leiomysarcoma Affects Fewer Than 150 People in the US</p><br clear="all"/>http://news.yahoo.com/boston-man-quits-job-cure-wifes-rare-cancer-004911331--abc-news-health.htmlWed, 03 Jul 2013 20:49:11 -0400Good Morning Americaboston-man-quits-job-cure-wifes-rare-cancer-004911331--abc-news-health<p><a href="http://news.yahoo.com/boston-man-quits-job-cure-wifes-rare-cancer-004911331--abc-news-health.html"><img src="http://l1.yimg.com/bt/api/res/1.2/xwMtXtS6MgDDxHTo8y5anw--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://l.yimg.com/os/590/2013/07/04/ht-erica-rick-kaitz-cancer-thg-130703-16x9-992-jpg_110740.jpg" width="130" height="86" alt="Boston Man Quits Job to Find Cure for Wife&#039;s Rare Cancer" align="left" title="Boston Man Quits Job to Find Cure for Wife&#039;s Rare Cancer" border="0" /></a>Orphan Disease Myxoid Leiomysarcoma Affects Fewer Than 150 People in the US</p><br clear="all"/>Canadian researchers studying breast cancer have found that the risk of developing the disease doubles after a woman works night shifts for at least 30 years. Their work expands research confined to the effect of shift work on healthcare workers.http://news.yahoo.com/study-says-decades-night-shifts-double-breast-cancer-222500977.htmlTue, 02 Jul 2013 18:25:00 -0400Yahoo! Contributor Networkstudy-says-decades-night-shifts-double-breast-cancer-222500977By Genevra Pittman NEW YORK (Reuters Health) - People who eat a diet high in fiber-rich whole grains are less likely to develop diabetes or heart disease, according to a review of past studies. The analysis was conducted for the American Society for Nutrition. In a position statement, the group said evidence suggests foods with cereal fiber or mixtures of whole grains and bran are "modestly associated" with a reduced disease risk. The strongest evidence for benefit came from cereal fiber, researchers said. ...http://news.yahoo.com/fiber-rich-grains-tied-lower-diabetes-risk-192944154.htmlTue, 02 Jul 2013 15:29:44 -0400Reutersfiber-rich-grains-tied-lower-diabetes-risk-192944154

Source: http://rss.news.yahoo.com/rss/diseases

Savages Home Run Derby 2012 San Diego fireworks steve nash Malware Monday First Row Sports 4th Of July Desserts